0.017599 0.000000 0.000000 0.000000 0.016431 0.000000 0.000000 0.000000 0.030003 0.00000 0.00000 0.00000 Inaka, K. Matsushima, M. Kuroki, R. Taniyama, Y. Kikuchi, M. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 4 90.00 90.00 90.00 56.820 60.860 33.330 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking H2 O 18.015 WATER non-polymer C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US Biochemistry BICHAW 0033 0006-2960 31 8323 8328 10.1021/bi00150a028 1525170 Enthalpic destabilization of a mutant human lysozyme lacking a disulfide bridge between cysteine-77 and cysteine-95. 1992 US J.Biol.Chem. JBCHA3 0071 0021-9258 266 12599 The Crystal Structure of a Mutant Human Lysozyme C77(Slash)95A with Increased Secretion Efficiency in Yeast 1991 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 1 x-ray 1 1.0 14688.627 HUMAN LYSOZYME 3.2.1.17 1 man polymer 18.015 water 57 nat water no no KVFERCELARTLKRLGMDGYRGISLANWMCLAKWESGYNTRATNYNAGDRSTDYGIFQINSRYWCNDGKTPGAVNAAHLS CSALLQDNIADAVACAKRVVRDPQGIRAWVAWRNRCQNRDVRQYVQGCGV KVFERCELARTLKRLGMDGYRGISLANWMCLAKWESGYNTRATNYNAGDRSTDYGIFQINSRYWCNDGKTPGAVNAAHLS CSALLQDNIADAVACAKRVVRDPQGIRAWVAWRNRCQNRDVRQYVQGCGV A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n human Homo sample 9606 Homo sapiens 1.96 37.29 pdbx_database_status struct_conf struct_conf_type repository Initial release Version format compliance Version format compliance Derived calculations Other 1 0 1993-10-31 1 1 2008-03-24 1 2 2011-07-13 1 3 2017-11-29 _pdbx_database_status.process_site Y BNL 1993-02-03 REL HOH water HOH 131 2 HOH HOH 131 A HOH 132 2 HOH HOH 132 A HOH 133 2 HOH HOH 133 A HOH 134 2 HOH HOH 134 A HOH 135 2 HOH HOH 135 A HOH 136 2 HOH HOH 136 A HOH 137 2 HOH HOH 137 A HOH 138 2 HOH HOH 138 A HOH 139 2 HOH HOH 139 A HOH 140 2 HOH HOH 140 A HOH 141 2 HOH HOH 141 A HOH 142 2 HOH HOH 142 A HOH 143 2 HOH HOH 143 A HOH 144 2 HOH HOH 144 A HOH 145 2 HOH HOH 145 A HOH 146 2 HOH HOH 146 A HOH 147 2 HOH HOH 147 A HOH 148 2 HOH HOH 148 A HOH 149 2 HOH HOH 149 A HOH 150 2 HOH HOH 150 A HOH 151 2 HOH HOH 151 A HOH 152 2 HOH HOH 152 A HOH 153 2 HOH HOH 153 A HOH 154 2 HOH HOH 154 A HOH 155 2 HOH HOH 155 A HOH 156 2 HOH HOH 156 A HOH 157 2 HOH HOH 157 A HOH 158 2 HOH HOH 158 A HOH 159 2 HOH HOH 159 A HOH 160 2 HOH HOH 160 A HOH 161 2 HOH HOH 161 A HOH 162 2 HOH HOH 162 A HOH 163 2 HOH HOH 163 A HOH 164 2 HOH HOH 164 A HOH 165 2 HOH HOH 165 A HOH 166 2 HOH HOH 166 A HOH 167 2 HOH HOH 167 A HOH 168 2 HOH HOH 168 A HOH 169 2 HOH HOH 169 A HOH 170 2 HOH HOH 170 A HOH 171 2 HOH HOH 171 A HOH 172 2 HOH HOH 172 A HOH 173 2 HOH HOH 173 A HOH 174 2 HOH HOH 174 A HOH 175 2 HOH HOH 175 A HOH 176 2 HOH HOH 176 A HOH 177 2 HOH HOH 177 A HOH 178 2 HOH HOH 178 A HOH 179 2 HOH HOH 179 A HOH 180 2 HOH HOH 180 A HOH 181 2 HOH HOH 181 A HOH 182 2 HOH HOH 182 A HOH 183 2 HOH HOH 183 A HOH 184 2 HOH HOH 184 A HOH 185 2 HOH HOH 185 A HOH 186 2 HOH HOH 186 A HOH 187 2 HOH HOH 187 A LYS 1 n 1 LYS 1 A VAL 2 n 2 VAL 2 A PHE 3 n 3 PHE 3 A GLU 4 n 4 GLU 4 A ARG 5 n 5 ARG 5 A CYS 6 n 6 CYS 6 A GLU 7 n 7 GLU 7 A LEU 8 n 8 LEU 8 A ALA 9 n 9 ALA 9 A ARG 10 n 10 ARG 10 A THR 11 n 11 THR 11 A LEU 12 n 12 LEU 12 A LYS 13 n 13 LYS 13 A ARG 14 n 14 ARG 14 A LEU 15 n 15 LEU 15 A GLY 16 n 16 GLY 16 A MET 17 n 17 MET 17 A ASP 18 n 18 ASP 18 A GLY 19 n 19 GLY 19 A TYR 20 n 20 TYR 20 A ARG 21 n 21 ARG 21 A GLY 22 n 22 GLY 22 A ILE 23 n 23 ILE 23 A SER 24 n 24 SER 24 A LEU 25 n 25 LEU 25 A ALA 26 n 26 ALA 26 A ASN 27 n 27 ASN 27 A TRP 28 n 28 TRP 28 A MET 29 n 29 MET 29 A CYS 30 n 30 CYS 30 A LEU 31 n 31 LEU 31 A ALA 32 n 32 ALA 32 A LYS 33 n 33 LYS 33 A TRP 34 n 34 TRP 34 A GLU 35 n 35 GLU 35 A SER 36 n 36 SER 36 A GLY 37 n 37 GLY 37 A TYR 38 n 38 TYR 38 A ASN 39 n 39 ASN 39 A THR 40 n 40 THR 40 A ARG 41 n 41 ARG 41 A ALA 42 n 42 ALA 42 A THR 43 n 43 THR 43 A ASN 44 n 44 ASN 44 A TYR 45 n 45 TYR 45 A ASN 46 n 46 ASN 46 A ALA 47 n 47 ALA 47 A GLY 48 n 48 GLY 48 A ASP 49 n 49 ASP 49 A ARG 50 n 50 ARG 50 A SER 51 n 51 SER 51 A THR 52 n 52 THR 52 A ASP 53 n 53 ASP 53 A TYR 54 n 54 TYR 54 A GLY 55 n 55 GLY 55 A ILE 56 n 56 ILE 56 A PHE 57 n 57 PHE 57 A GLN 58 n 58 GLN 58 A ILE 59 n 59 ILE 59 A ASN 60 n 60 ASN 60 A SER 61 n 61 SER 61 A ARG 62 n 62 ARG 62 A TYR 63 n 63 TYR 63 A TRP 64 n 64 TRP 64 A CYS 65 n 65 CYS 65 A ASN 66 n 66 ASN 66 A ASP 67 n 67 ASP 67 A GLY 68 n 68 GLY 68 A LYS 69 n 69 LYS 69 A THR 70 n 70 THR 70 A PRO 71 n 71 PRO 71 A GLY 72 n 72 GLY 72 A ALA 73 n 73 ALA 73 A VAL 74 n 74 VAL 74 A ASN 75 n 75 ASN 75 A ALA 76 n 76 ALA 76 A ALA 77 n 77 ALA 77 A HIS 78 n 78 HIS 78 A LEU 79 n 79 LEU 79 A SER 80 n 80 SER 80 A CYS 81 n 81 CYS 81 A SER 82 n 82 SER 82 A ALA 83 n 83 ALA 83 A LEU 84 n 84 LEU 84 A LEU 85 n 85 LEU 85 A GLN 86 n 86 GLN 86 A ASP 87 n 87 ASP 87 A ASN 88 n 88 ASN 88 A ILE 89 n 89 ILE 89 A ALA 90 n 90 ALA 90 A ASP 91 n 91 ASP 91 A ALA 92 n 92 ALA 92 A VAL 93 n 93 VAL 93 A ALA 94 n 94 ALA 94 A CYS 95 n 95 CYS 95 A ALA 96 n 96 ALA 96 A LYS 97 n 97 LYS 97 A ARG 98 n 98 ARG 98 A VAL 99 n 99 VAL 99 A VAL 100 n 100 VAL 100 A ARG 101 n 101 ARG 101 A ASP 102 n 102 ASP 102 A PRO 103 n 103 PRO 103 A GLN 104 n 104 GLN 104 A GLY 105 n 105 GLY 105 A ILE 106 n 106 ILE 106 A ARG 107 n 107 ARG 107 A ALA 108 n 108 ALA 108 A TRP 109 n 109 TRP 109 A VAL 110 n 110 VAL 110 A ALA 111 n 111 ALA 111 A TRP 112 n 112 TRP 112 A ARG 113 n 113 ARG 113 A ASN 114 n 114 ASN 114 A ARG 115 n 115 ARG 115 A CYS 116 n 116 CYS 116 A GLN 117 n 117 GLN 117 A ASN 118 n 118 ASN 118 A ARG 119 n 119 ARG 119 A ASP 120 n 120 ASP 120 A VAL 121 n 121 VAL 121 A ARG 122 n 122 ARG 122 A GLN 123 n 123 GLN 123 A TYR 124 n 124 TYR 124 A VAL 125 n 125 VAL 125 A GLN 126 n 126 GLN 126 A GLY 127 n 127 GLY 127 A CYS 128 n 128 CYS 128 A GLY 129 n 129 GLY 129 A VAL 130 n 130 VAL 130 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 A O LYS 1 A O LYS 1 A N THR 40 A N THR 40 A O ALA 42 A O ALA 42 A N GLY 55 A N GLY 55 A O THR 52 A O THR 52 A N SER 61 A N SER 61 1 A CG ARG 14 A CG ARG 14 1 Y 1 A CD ARG 14 A CD ARG 14 1 Y 1 A NE ARG 14 A NE ARG 14 1 Y 1 A CZ ARG 14 A CZ ARG 14 1 Y 1 A NH1 ARG 14 A NH1 ARG 14 1 Y 1 A NH2 ARG 14 A NH2 ARG 14 1 Y 1 A CG ARG 41 A CG ARG 41 1 Y 1 A CD ARG 41 A CD ARG 41 1 Y 1 A NE ARG 41 A NE ARG 41 1 Y 1 A CZ ARG 41 A CZ ARG 41 1 Y 1 A NH1 ARG 41 A NH1 ARG 41 1 Y 1 A NH2 ARG 41 A NH2 ARG 41 1 Y 1 8.25 1.20 123.30 131.55 A A A OE1 CD OE2 GLU GLU GLU 4 4 4 N 1 12.49 2.00 118.30 130.79 A A A CG CD OE1 GLU GLU GLU 7 7 7 N 1 -14.65 2.00 118.30 103.65 A A A CG CD OE2 GLU GLU GLU 7 7 7 N 1 -4.46 0.50 120.30 115.84 A A A NE CZ NH1 ARG ARG ARG 10 10 10 N 1 7.81 0.90 118.30 126.11 A A A CB CG OD1 ASP ASP ASP 18 18 18 N 1 3.33 0.50 120.30 123.63 A A A NE CZ NH1 ARG ARG ARG 21 21 21 N 1 -6.79 0.50 120.30 113.51 A A A NE CZ NH2 ARG ARG ARG 21 21 21 N 1 14.79 1.40 123.60 138.39 A A A CD NE CZ ARG ARG ARG 50 50 50 N 1 7.84 0.50 120.30 128.14 A A A NE CZ NH1 ARG ARG ARG 50 50 50 N 1 -3.52 0.50 120.30 116.78 A A A NE CZ NH2 ARG ARG ARG 50 50 50 N 1 -8.71 0.90 118.30 109.59 A A A CB CG OD2 ASP ASP ASP 53 53 53 N 1 -3.66 0.50 120.30 116.64 A A A NE CZ NH1 ARG ARG ARG 62 62 62 N 1 3.69 0.50 120.30 123.99 A A A NE CZ NH2 ARG ARG ARG 62 62 62 N 1 6.09 0.90 118.30 124.39 A A A CB CG OD1 ASP ASP ASP 87 87 87 N 1 5.52 0.50 120.30 125.82 A A A NE CZ NH1 ARG ARG ARG 98 98 98 N 1 -7.47 0.50 120.30 112.83 A A A NE CZ NH2 ARG ARG ARG 98 98 98 N 1 5.88 0.90 118.30 124.18 A A A CB CG OD1 ASP ASP ASP 102 102 102 N 1 4.50 0.50 120.30 124.80 A A A NE CZ NH1 ARG ARG ARG 107 107 107 N 1 -3.50 0.50 120.30 116.80 A A A NE CZ NH2 ARG ARG ARG 107 107 107 N 1 -4.75 0.50 120.30 115.55 A A A NE CZ NH2 ARG ARG ARG 113 113 113 N 1 3.20 0.50 120.30 123.50 A A A NE CZ NH1 ARG ARG ARG 115 115 115 N 1 -5.21 0.50 120.30 115.09 A A A NE CZ NH2 ARG ARG ARG 115 115 115 N 1 -3.47 0.50 120.30 116.83 A A A NE CZ NH1 ARG ARG ARG 119 119 119 N 1 3.43 0.50 120.30 123.73 A A A NE CZ NH2 ARG ARG ARG 119 119 119 N 1 -5.59 0.90 118.30 112.71 A A A CB CG OD2 ASP ASP ASP 120 120 120 N THE ELECTRON DENSITIES OF THE LOOP BETWEEN ALA 73 AND HIS 78 ARE VERY WEAK AND THE ATOMS OF THE LOOP HAVE LARGE B FACTORS. THEN THE LOOP CAN BE VERY FLEXIBLE. 0.188 1.8 5.0 10265 1 1.8 5.0 57 1073 0 0 1016 refinement PROLSQ LYSOZYME (E.C.3.2.1.17) MUTANT WITH CYS 77 REPLACED BY ALA (C77A) ENTHALPIC DESTABILIZATION OF A MUTANT HUMAN LYSOZYME LACKING A DISULFIDE BRIDGE BETWEEN CYSTEINE-77 AND CYSTEINE-95 1 N N 2 N N A ARG 5 A ARG 5 HELX_P A ARG 14 A ARG 14 1 A 10 A LEU 25 A LEU 25 HELX_P A GLU 35 A GLU 35 1 B 11 A SER 80 A SER 80 HELX_P A LEU 85 A LEU 85 5 E 6 A ALA 90 A ALA 90 HELX_P A VAL 99 A VAL 99 1 C 10 A VAL 110 A VAL 110 HELX_P A CYS 116 A CYS 116 1 D 7 disulf 2.034 A CYS 6 A SG CYS 6 1_555 A CYS 128 A SG CYS 128 1_555 disulf 2.059 A CYS 30 A SG CYS 30 1_555 A CYS 116 A SG CYS 116 1_555 disulf 2.074 A CYS 65 A SG CYS 65 1_555 A CYS 81 A SG CYS 81 1_555 HYDROLASE(O-GLYCOSYL) HYDROLASE(O-GLYCOSYL) LYSC_HUMAN UNP 1 1 P61626 MKALIVLGLVLLSVTVQGKVFERCELARTLKRLGMDGYRGISLANWMCLAKWESGYNTRATNYNAGDRSTDYGIFQINSR YWCNDGKTPGAVNACHLSCSALLQDNIADAVACAKRVVRDPQGIRAWVAWRNRCQNRDVRQYVQGCGV 19 148 1LZ4 1 130 P61626 A 1 1 130 1 CYS CONFLICT ALA 77 1LZ4 A P61626 UNP 95 77 2 3 anti-parallel anti-parallel anti-parallel A LYS 1 A LYS 1 A PHE 3 A PHE 3 A TYR 38 A TYR 38 A THR 40 A THR 40 A ALA 42 A ALA 42 A ASN 46 A ASN 46 A SER 51 A SER 51 A GLY 55 A GLY 55 A ILE 59 A ILE 59 A SER 61 A SER 61 19 P 21 21 21